Haixiu Ma, Lina Suo, Jing Zhao, Ronghua Ma, Qi Wang, Jun Liu, Jinwan Qiao, Juan Wu, Juan An, Yan Liu, Yonghua Xing, Haiyan Wang, Zhanhai Su
{"title":"基于影响胃癌细胞迁移的 GUF1、EFTUD2 和 GSPT1 靶点的预后生物标志物。","authors":"Haixiu Ma, Lina Suo, Jing Zhao, Ronghua Ma, Qi Wang, Jun Liu, Jinwan Qiao, Juan Wu, Juan An, Yan Liu, Yonghua Xing, Haiyan Wang, Zhanhai Su","doi":"10.21037/tcr-24-125","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Eukaryotic elongation factor 1 alpha 2 (eEF1A2) is a protein coding gene which is involved in tumor development and progression in several types of human cancer, but little is known about the function of eEF1A2 proteins in gastric cancer (GC). This study aimed to investigate the effects of <i>GUF1</i>, <i>EFTUD2</i> and <i>GSPT1</i> on the migration of GC cells.</p><p><strong>Methods: </strong>The Oncomine and The Cancer Genome Atlas (TCGA) databases were used to evaluate the expression of <i>GUF1</i>, <i>EFTUD2</i>, <i>GSPT1</i> and <i>GSPT2</i> in GC and the association of eEF1A2 family with individual clinical characteristics. Kaplan-Meier (K-M) Plotter hinted the prognostic value of <i>GUF1</i>, <i>EFTUD2</i>, <i>GSPT1</i> and <i>GSPT2</i>. GSE62254 and GSE66222 datasets were used to validate the expression of <i>GUF1</i>, <i>EFTUD2</i>, <i>GSPT1</i>. AGS cell line and GES line were also used for validating the function of <i>GUF1</i>, <i>EFTUD2</i>, <i>GSPT1</i>. RNA interference (RNAi) of GUF1, EFTUD2 and GSPT1 had been used to query those genes expression pattern and dissect the proliferation and migration in GC cell lines.</p><p><strong>Results: </strong><i>GUF1</i>, <i>EFTUD2</i> and <i>GSPT1</i> were significantly up-regulated in GC cell lines. High expression of <i>GUF1</i>, <i>EFTUD2</i> and <i>GSPT1</i> was correlated with cell proliferation and migration induced in GC cells. <i>GUF1</i>, <i>EFTUD2</i> and <i>GSPT1</i> may be potential novel oncogenes that helps to maintain the survival of GC cells.</p><p><strong>Conclusions: </strong>This study identified that high levels of <i>GUF1</i>, <i>EFTUD2</i> and <i>GSPT1</i> expression are predictive biomarkers for a poor prognosis in GC.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"13 9","pages":"4827-4845"},"PeriodicalIF":1.5000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11483415/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prognostic biomarkers based on <i>GUF1</i>, <i>EFTUD2</i> and <i>GSPT1</i> targets affecting migration of gastric cancer cells.\",\"authors\":\"Haixiu Ma, Lina Suo, Jing Zhao, Ronghua Ma, Qi Wang, Jun Liu, Jinwan Qiao, Juan Wu, Juan An, Yan Liu, Yonghua Xing, Haiyan Wang, Zhanhai Su\",\"doi\":\"10.21037/tcr-24-125\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Eukaryotic elongation factor 1 alpha 2 (eEF1A2) is a protein coding gene which is involved in tumor development and progression in several types of human cancer, but little is known about the function of eEF1A2 proteins in gastric cancer (GC). This study aimed to investigate the effects of <i>GUF1</i>, <i>EFTUD2</i> and <i>GSPT1</i> on the migration of GC cells.</p><p><strong>Methods: </strong>The Oncomine and The Cancer Genome Atlas (TCGA) databases were used to evaluate the expression of <i>GUF1</i>, <i>EFTUD2</i>, <i>GSPT1</i> and <i>GSPT2</i> in GC and the association of eEF1A2 family with individual clinical characteristics. Kaplan-Meier (K-M) Plotter hinted the prognostic value of <i>GUF1</i>, <i>EFTUD2</i>, <i>GSPT1</i> and <i>GSPT2</i>. GSE62254 and GSE66222 datasets were used to validate the expression of <i>GUF1</i>, <i>EFTUD2</i>, <i>GSPT1</i>. AGS cell line and GES line were also used for validating the function of <i>GUF1</i>, <i>EFTUD2</i>, <i>GSPT1</i>. RNA interference (RNAi) of GUF1, EFTUD2 and GSPT1 had been used to query those genes expression pattern and dissect the proliferation and migration in GC cell lines.</p><p><strong>Results: </strong><i>GUF1</i>, <i>EFTUD2</i> and <i>GSPT1</i> were significantly up-regulated in GC cell lines. High expression of <i>GUF1</i>, <i>EFTUD2</i> and <i>GSPT1</i> was correlated with cell proliferation and migration induced in GC cells. <i>GUF1</i>, <i>EFTUD2</i> and <i>GSPT1</i> may be potential novel oncogenes that helps to maintain the survival of GC cells.</p><p><strong>Conclusions: </strong>This study identified that high levels of <i>GUF1</i>, <i>EFTUD2</i> and <i>GSPT1</i> expression are predictive biomarkers for a poor prognosis in GC.</p>\",\"PeriodicalId\":23216,\"journal\":{\"name\":\"Translational cancer research\",\"volume\":\"13 9\",\"pages\":\"4827-4845\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11483415/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational cancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21037/tcr-24-125\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/9/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-24-125","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/27 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Prognostic biomarkers based on GUF1, EFTUD2 and GSPT1 targets affecting migration of gastric cancer cells.
Background: Eukaryotic elongation factor 1 alpha 2 (eEF1A2) is a protein coding gene which is involved in tumor development and progression in several types of human cancer, but little is known about the function of eEF1A2 proteins in gastric cancer (GC). This study aimed to investigate the effects of GUF1, EFTUD2 and GSPT1 on the migration of GC cells.
Methods: The Oncomine and The Cancer Genome Atlas (TCGA) databases were used to evaluate the expression of GUF1, EFTUD2, GSPT1 and GSPT2 in GC and the association of eEF1A2 family with individual clinical characteristics. Kaplan-Meier (K-M) Plotter hinted the prognostic value of GUF1, EFTUD2, GSPT1 and GSPT2. GSE62254 and GSE66222 datasets were used to validate the expression of GUF1, EFTUD2, GSPT1. AGS cell line and GES line were also used for validating the function of GUF1, EFTUD2, GSPT1. RNA interference (RNAi) of GUF1, EFTUD2 and GSPT1 had been used to query those genes expression pattern and dissect the proliferation and migration in GC cell lines.
Results: GUF1, EFTUD2 and GSPT1 were significantly up-regulated in GC cell lines. High expression of GUF1, EFTUD2 and GSPT1 was correlated with cell proliferation and migration induced in GC cells. GUF1, EFTUD2 and GSPT1 may be potential novel oncogenes that helps to maintain the survival of GC cells.
Conclusions: This study identified that high levels of GUF1, EFTUD2 and GSPT1 expression are predictive biomarkers for a poor prognosis in GC.
期刊介绍：
Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
